tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Cash flow

Compare
4 Followers

Everest Medicines Ltd. Cash Flow

HK:1952's free cash flow for Q2 2025 was ¥-102.92M. For the 2025 fiscal year, HK:1952's free cash flow was decreased by ¥290.22M and operating cash flow was ¥-90.74M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ -679.51M¥ -769.19M¥ -1.16B¥ -729.94M¥ -471.90M
Investing Cash Flow
¥ 974.40M¥ 752.50M¥ -1.03B¥ -975.82M¥ -519.93M
Financing Cash Flow
¥ 37.80M¥ 10.10M¥ -25.31M¥ -76.51M¥ 5.64B
End Cash Position
¥ 884.47M¥ 523.06M¥ 490.79M¥ 2.64B¥ 4.48B
Free Cash Flow
¥ -744.92M¥ -1.04B¥ -1.59B¥ -1.71B¥ -991.83M
Currency in CNY

Everest Medicines Ltd. Cash Flow